SCHEDULE 13G/A - Akero Therapeutics, Inc. (0001744659) (Subject) | Filings Insight

Akero Therapeutics, Inc.

0001744659 Nasdaq

SCHEDULE 13G/A - Akero Therapeutics, Inc. (0001744659) (Subject)[0]

[SCHEDULE 13G/A](접수일: 2025-08-14)

[SUBJECT COMPANY]Akero Therapeutics, Inc. | [FILED BY]RTW INVESTMENTS, LP |

/ 0